These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12180712)

  • 1. The concept of disease modification in spondyloarthropathy.
    Marzo-Ortega H; Emery P; McGonagle D
    J Rheumatol; 2002 Aug; 29(8):1583-5. PubMed ID: 12180712
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
    Van den Bosch F; De Keyser F; Mielants H; Veys EM
    Arthritis Res Ther; 2005; 7(3):121-3. PubMed ID: 15899063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current world literature.
    Curr Opin Rheumatol; 2010 May; 22(3):348-61. PubMed ID: 20351495
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Buckley C; Silman AJ; Symmons DP; Bruce IN
    J Rheumatol; 2005 Jan; 32(1):11-16. PubMed ID: 15700388
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on 'Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry'.
    Feldtkeller E; Rudwaleit M
    Ann Rheum Dis; 2014 Dec; 73(12):e77. PubMed ID: 25252720
    [No Abstract]   [Full Text] [Related]  

  • 6. Is it time for a European consensus on the pharmacological management of early RA?
    Emery P
    J Rheumatol Suppl; 2002 Nov; 66():1-2. PubMed ID: 12435161
    [No Abstract]   [Full Text] [Related]  

  • 7. Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Bruce IN; Silman AJ; Symmons DP
    J Rheumatol; 2005 Jan; 32(1):6-10. PubMed ID: 15630715
    [No Abstract]   [Full Text] [Related]  

  • 8. Whither the ACR20?
    Felson DT
    J Rheumatol; 2004 May; 31(5):835-7. PubMed ID: 15124237
    [No Abstract]   [Full Text] [Related]  

  • 9. Just released from the ASAS factory! First steps towards a disease activity score for ankylosing spondylitis.
    Boers M
    Ann Rheum Dis; 2009 Jan; 68(1):1-2. PubMed ID: 19088258
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inflammatory rheumatic diseases].
    Kellner H
    MMW Fortschr Med; 2009 Apr; 151(14):67-70; quiz 71. PubMed ID: 19504844
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription rheumatology practices among Mexican specialists.
    Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
    Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic comparison of rheumatoid arthritis and ankylosing spondylitis: non-steroidal anti-inflammatory drugs.
    Poddubnyy D; Song IH; Sieper J
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S148-51. PubMed ID: 19822063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to eLetter by Feldtkeller et al.
    Sørensen J; Hetland ML
    Ann Rheum Dis; 2014 Dec; 73(12):e78. PubMed ID: 25281722
    [No Abstract]   [Full Text] [Related]  

  • 14. [Revision of the recommendations of the Commission on Pharmacotherapy of the German society for Rheumatology. Therapy with tumour necrosis factor blockers for inflammatory rheumatic illnesses].
    Manger B; Michels H; Nüsslein HG; Schneider M; Sieper J;
    Z Rheumatol; 2007 Feb; 66(1):72-5. PubMed ID: 17221253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?
    Goodemote P; Jamieson B; Hoffman R
    J Fam Pract; 2007 Nov; 56(11):933-4, 937. PubMed ID: 17976342
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of rheumatoid arthritis. The Danish Society of Rheumatology].
    Bestyrelsen
    Ugeskr Laeger; 2000 Mar; 162(12):1715. PubMed ID: 10745662
    [No Abstract]   [Full Text] [Related]  

  • 17. Issues in rheumatology and autoimmunity. Preface.
    Sherer Y
    Isr Med Assoc J; 2008 Feb; 10(2):138. PubMed ID: 18432028
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintaining and optimising anti-TNF therapy.
    Somerville M
    Musculoskeletal Care; 2007 Dec; 5 Suppl 1():1-17. PubMed ID: 18050263
    [No Abstract]   [Full Text] [Related]  

  • 19. Rheumatology mini focus.
    Scheinman RI
    Future Med Chem; 2012 Apr; 4(6):697-9. PubMed ID: 22530632
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rheumatoid arthritis and ankylosing spondylitis--rheumatologic highlights 2007].
    Dudler J; Aubry-Rozier B
    Rev Med Suisse; 2008 Jan; 4(139):67-8, 70-1. PubMed ID: 18251219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.